Ever bite into a supermarket tomato and wonder where all the flavor went? You're not imagining things. That watery, cardboard ...

Discover how scientists engineered goldenberry plants to grow 35% shorter than usual, making them suitable for large-scale ...

Both stocks are risky, but one is far less so. This juicy upside potential comes at a cost. Investors seeking stocks with ...

Goldenberries taste like a cross between pineapple and mango, pack the nutritional punch of a superfood, and are increasingly ...

Casgevy, now a "national priority" drug, helped kids with sickle cell and thalassemia, results which may help toward a label ...

Scientists grew a microscopic fungus into a more efficient — and meat-like — edible protein by tweaking just two genes with ...

A bespoke CRISPR base-editing therapy designed for a single infant with CPS1 deficiency has produced encouraging early ...

Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...

Wheat that can help make its own fertilizer is no longer a speculative idea from plant biology textbooks, it is a working ...

Despite a challenging CASGEVY launch, high cash burn, and an almost 10% YTD share count growth, CRISPR’s pipeline breadth and ...

A new FDA pathway could speed bespoke gene therapies, but key questions over scope and commercial viability remain.